Global Acquired Immunodeficiency Syndrome Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Acquired Immunodeficiency Syndrome market size was valued at US$ 1502.6 million in 2023. With growing demand in downstream market, the Acquired Immunodeficiency Syndrome is forecast to a readjusted size of US$ 1942.2 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Acquired Immunodeficiency Syndrome market. Acquired Immunodeficiency Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Acquired Immunodeficiency Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Acquired Immunodeficiency Syndrome market.
Acquired immunodeficiency syndrome (AIDS) is one of the most widespread, catastrophic, and incurable diseases among humans in the world. According to a report published by the World Health Organization (WHO) in 2013, deaths caused by HIV ranked sixth in the total number of deaths in the world. Human immunodeficiency virus (HIV) presents itself as a complex mixture of symptoms, all related to severe immune compromise, while AIDS is an advanced stage of HIV infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Acquired Immunodeficiency Syndrome market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Acquired Immunodeficiency Syndrome market. It may include historical data, market segmentation by Type (e.g., Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Acquired Immunodeficiency Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Acquired Immunodeficiency Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Acquired Immunodeficiency Syndrome industry. This include advancements in Acquired Immunodeficiency Syndrome technology, Acquired Immunodeficiency Syndrome new entrants, Acquired Immunodeficiency Syndrome new investment, and other innovations that are shaping the future of Acquired Immunodeficiency Syndrome.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Acquired Immunodeficiency Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Acquired Immunodeficiency Syndrome product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Acquired Immunodeficiency Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Acquired Immunodeficiency Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Acquired Immunodeficiency Syndrome market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Acquired Immunodeficiency Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Acquired Immunodeficiency Syndrome market.
Market Segmentation:
Acquired Immunodeficiency Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Acquired Immunodeficiency Syndrome market size was valued at US$ 1502.6 million in 2023. With growing demand in downstream market, the Acquired Immunodeficiency Syndrome is forecast to a readjusted size of US$ 1942.2 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Acquired Immunodeficiency Syndrome market. Acquired Immunodeficiency Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Acquired Immunodeficiency Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Acquired Immunodeficiency Syndrome market.
Acquired immunodeficiency syndrome (AIDS) is one of the most widespread, catastrophic, and incurable diseases among humans in the world. According to a report published by the World Health Organization (WHO) in 2013, deaths caused by HIV ranked sixth in the total number of deaths in the world. Human immunodeficiency virus (HIV) presents itself as a complex mixture of symptoms, all related to severe immune compromise, while AIDS is an advanced stage of HIV infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Acquired Immunodeficiency Syndrome market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Acquired Immunodeficiency Syndrome market. It may include historical data, market segmentation by Type (e.g., Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Acquired Immunodeficiency Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Acquired Immunodeficiency Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Acquired Immunodeficiency Syndrome industry. This include advancements in Acquired Immunodeficiency Syndrome technology, Acquired Immunodeficiency Syndrome new entrants, Acquired Immunodeficiency Syndrome new investment, and other innovations that are shaping the future of Acquired Immunodeficiency Syndrome.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Acquired Immunodeficiency Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Acquired Immunodeficiency Syndrome product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Acquired Immunodeficiency Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Acquired Immunodeficiency Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Acquired Immunodeficiency Syndrome market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Acquired Immunodeficiency Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Acquired Immunodeficiency Syndrome market.
Market Segmentation:
Acquired Immunodeficiency Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- AstraZeneca Eli Lilly and Company
- Merck KGaA
- Sanofi
- Pfizer
- Amgen
- Biogen
- Novartis
- Actelion
- Daiichi Sankyo Company
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acquired Immunodeficiency Syndrome Market Size 2019-2030
2.1.2 Acquired Immunodeficiency Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Acquired Immunodeficiency Syndrome Segment by Type
2.2.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.3 Acquired Immunodeficiency Syndrome Market Size by Type
2.3.1 Acquired Immunodeficiency Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
2.4 Acquired Immunodeficiency Syndrome Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Acquired Immunodeficiency Syndrome Market Size by Application
2.5.1 Acquired Immunodeficiency Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
3 ACQUIRED IMMUNODEFICIENCY SYNDROME MARKET SIZE BY PLAYER
3.1 Acquired Immunodeficiency Syndrome Market Size Market Share by Players
3.1.1 Global Acquired Immunodeficiency Syndrome Revenue by Players (2019-2024)
3.1.2 Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Acquired Immunodeficiency Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACQUIRED IMMUNODEFICIENCY SYNDROME BY REGIONS
4.1 Acquired Immunodeficiency Syndrome Market Size by Regions (2019-2024)
4.2 Americas Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.3 APAC Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.4 Europe Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024)
5.2 Americas Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
5.3 Americas Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024)
6.2 APAC Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
6.3 APAC Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acquired Immunodeficiency Syndrome by Country (2019-2024)
7.2 Europe Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
7.3 Europe Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acquired Immunodeficiency Syndrome by Region (2019-2024)
8.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACQUIRED IMMUNODEFICIENCY SYNDROME MARKET FORECAST
10.1 Global Acquired Immunodeficiency Syndrome Forecast by Regions (2025-2030)
10.1.1 Global Acquired Immunodeficiency Syndrome Forecast by Regions (2025-2030)
10.1.2 Americas Acquired Immunodeficiency Syndrome Forecast
10.1.3 APAC Acquired Immunodeficiency Syndrome Forecast
10.1.4 Europe Acquired Immunodeficiency Syndrome Forecast
10.1.5 Middle East & Africa Acquired Immunodeficiency Syndrome Forecast
10.2 Americas Acquired Immunodeficiency Syndrome Forecast by Country (2025-2030)
10.2.1 United States Acquired Immunodeficiency Syndrome Market Forecast
10.2.2 Canada Acquired Immunodeficiency Syndrome Market Forecast
10.2.3 Mexico Acquired Immunodeficiency Syndrome Market Forecast
10.2.4 Brazil Acquired Immunodeficiency Syndrome Market Forecast
10.3 APAC Acquired Immunodeficiency Syndrome Forecast by Region (2025-2030)
10.3.1 China Acquired Immunodeficiency Syndrome Market Forecast
10.3.2 Japan Acquired Immunodeficiency Syndrome Market Forecast
10.3.3 Korea Acquired Immunodeficiency Syndrome Market Forecast
10.3.4 Southeast Asia Acquired Immunodeficiency Syndrome Market Forecast
10.3.5 India Acquired Immunodeficiency Syndrome Market Forecast
10.3.6 Australia Acquired Immunodeficiency Syndrome Market Forecast
10.4 Europe Acquired Immunodeficiency Syndrome Forecast by Country (2025-2030)
10.4.1 Germany Acquired Immunodeficiency Syndrome Market Forecast
10.4.2 France Acquired Immunodeficiency Syndrome Market Forecast
10.4.3 UK Acquired Immunodeficiency Syndrome Market Forecast
10.4.4 Italy Acquired Immunodeficiency Syndrome Market Forecast
10.4.5 Russia Acquired Immunodeficiency Syndrome Market Forecast
10.5 Middle East & Africa Acquired Immunodeficiency Syndrome Forecast by Region (2025-2030)
10.5.1 Egypt Acquired Immunodeficiency Syndrome Market Forecast
10.5.2 South Africa Acquired Immunodeficiency Syndrome Market Forecast
10.5.3 Israel Acquired Immunodeficiency Syndrome Market Forecast
10.5.4 Turkey Acquired Immunodeficiency Syndrome Market Forecast
10.5.5 GCC Countries Acquired Immunodeficiency Syndrome Market Forecast
10.6 Global Acquired Immunodeficiency Syndrome Forecast by Type (2025-2030)
10.7 Global Acquired Immunodeficiency Syndrome Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Acquired Immunodeficiency Syndrome Product Offered
11.1.3 Takeda Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 AstraZeneca Eli Lilly and Company
11.2.1 AstraZeneca Eli Lilly and Company Company Information
11.2.2 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Offered
11.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Eli Lilly and Company Main Business Overview
11.2.5 AstraZeneca Eli Lilly and Company Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Acquired Immunodeficiency Syndrome Product Offered
11.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Acquired Immunodeficiency Syndrome Product Offered
11.4.3 Sanofi Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Acquired Immunodeficiency Syndrome Product Offered
11.5.3 Pfizer Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Acquired Immunodeficiency Syndrome Product Offered
11.6.3 Amgen Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Acquired Immunodeficiency Syndrome Product Offered
11.7.3 Biogen Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Acquired Immunodeficiency Syndrome Product Offered
11.8.3 Novartis Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Actelion
11.9.1 Actelion Company Information
11.9.2 Actelion Acquired Immunodeficiency Syndrome Product Offered
11.9.3 Actelion Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Actelion Main Business Overview
11.9.5 Actelion Latest Developments
11.10 Daiichi Sankyo Company
11.10.1 Daiichi Sankyo Company Company Information
11.10.2 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Offered
11.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Daiichi Sankyo Company Main Business Overview
11.10.5 Daiichi Sankyo Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acquired Immunodeficiency Syndrome Market Size 2019-2030
2.1.2 Acquired Immunodeficiency Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Acquired Immunodeficiency Syndrome Segment by Type
2.2.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.3 Acquired Immunodeficiency Syndrome Market Size by Type
2.3.1 Acquired Immunodeficiency Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
2.4 Acquired Immunodeficiency Syndrome Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Acquired Immunodeficiency Syndrome Market Size by Application
2.5.1 Acquired Immunodeficiency Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
3 ACQUIRED IMMUNODEFICIENCY SYNDROME MARKET SIZE BY PLAYER
3.1 Acquired Immunodeficiency Syndrome Market Size Market Share by Players
3.1.1 Global Acquired Immunodeficiency Syndrome Revenue by Players (2019-2024)
3.1.2 Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Acquired Immunodeficiency Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACQUIRED IMMUNODEFICIENCY SYNDROME BY REGIONS
4.1 Acquired Immunodeficiency Syndrome Market Size by Regions (2019-2024)
4.2 Americas Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.3 APAC Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.4 Europe Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024)
5.2 Americas Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
5.3 Americas Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024)
6.2 APAC Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
6.3 APAC Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acquired Immunodeficiency Syndrome by Country (2019-2024)
7.2 Europe Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
7.3 Europe Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acquired Immunodeficiency Syndrome by Region (2019-2024)
8.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACQUIRED IMMUNODEFICIENCY SYNDROME MARKET FORECAST
10.1 Global Acquired Immunodeficiency Syndrome Forecast by Regions (2025-2030)
10.1.1 Global Acquired Immunodeficiency Syndrome Forecast by Regions (2025-2030)
10.1.2 Americas Acquired Immunodeficiency Syndrome Forecast
10.1.3 APAC Acquired Immunodeficiency Syndrome Forecast
10.1.4 Europe Acquired Immunodeficiency Syndrome Forecast
10.1.5 Middle East & Africa Acquired Immunodeficiency Syndrome Forecast
10.2 Americas Acquired Immunodeficiency Syndrome Forecast by Country (2025-2030)
10.2.1 United States Acquired Immunodeficiency Syndrome Market Forecast
10.2.2 Canada Acquired Immunodeficiency Syndrome Market Forecast
10.2.3 Mexico Acquired Immunodeficiency Syndrome Market Forecast
10.2.4 Brazil Acquired Immunodeficiency Syndrome Market Forecast
10.3 APAC Acquired Immunodeficiency Syndrome Forecast by Region (2025-2030)
10.3.1 China Acquired Immunodeficiency Syndrome Market Forecast
10.3.2 Japan Acquired Immunodeficiency Syndrome Market Forecast
10.3.3 Korea Acquired Immunodeficiency Syndrome Market Forecast
10.3.4 Southeast Asia Acquired Immunodeficiency Syndrome Market Forecast
10.3.5 India Acquired Immunodeficiency Syndrome Market Forecast
10.3.6 Australia Acquired Immunodeficiency Syndrome Market Forecast
10.4 Europe Acquired Immunodeficiency Syndrome Forecast by Country (2025-2030)
10.4.1 Germany Acquired Immunodeficiency Syndrome Market Forecast
10.4.2 France Acquired Immunodeficiency Syndrome Market Forecast
10.4.3 UK Acquired Immunodeficiency Syndrome Market Forecast
10.4.4 Italy Acquired Immunodeficiency Syndrome Market Forecast
10.4.5 Russia Acquired Immunodeficiency Syndrome Market Forecast
10.5 Middle East & Africa Acquired Immunodeficiency Syndrome Forecast by Region (2025-2030)
10.5.1 Egypt Acquired Immunodeficiency Syndrome Market Forecast
10.5.2 South Africa Acquired Immunodeficiency Syndrome Market Forecast
10.5.3 Israel Acquired Immunodeficiency Syndrome Market Forecast
10.5.4 Turkey Acquired Immunodeficiency Syndrome Market Forecast
10.5.5 GCC Countries Acquired Immunodeficiency Syndrome Market Forecast
10.6 Global Acquired Immunodeficiency Syndrome Forecast by Type (2025-2030)
10.7 Global Acquired Immunodeficiency Syndrome Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Acquired Immunodeficiency Syndrome Product Offered
11.1.3 Takeda Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 AstraZeneca Eli Lilly and Company
11.2.1 AstraZeneca Eli Lilly and Company Company Information
11.2.2 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Offered
11.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Eli Lilly and Company Main Business Overview
11.2.5 AstraZeneca Eli Lilly and Company Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Acquired Immunodeficiency Syndrome Product Offered
11.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Acquired Immunodeficiency Syndrome Product Offered
11.4.3 Sanofi Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Acquired Immunodeficiency Syndrome Product Offered
11.5.3 Pfizer Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Acquired Immunodeficiency Syndrome Product Offered
11.6.3 Amgen Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Acquired Immunodeficiency Syndrome Product Offered
11.7.3 Biogen Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Acquired Immunodeficiency Syndrome Product Offered
11.8.3 Novartis Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Actelion
11.9.1 Actelion Company Information
11.9.2 Actelion Acquired Immunodeficiency Syndrome Product Offered
11.9.3 Actelion Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Actelion Main Business Overview
11.9.5 Actelion Latest Developments
11.10 Daiichi Sankyo Company
11.10.1 Daiichi Sankyo Company Company Information
11.10.2 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Offered
11.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Daiichi Sankyo Company Main Business Overview
11.10.5 Daiichi Sankyo Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acquired Immunodeficiency Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Major Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Acquired Immunodeficiency Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 7. Acquired Immunodeficiency Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 10. Global Acquired Immunodeficiency Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Player (2019-2024)
Table 12. Acquired Immunodeficiency Syndrome Key Players Head office and Products Offered
Table 13. Acquired Immunodeficiency Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Acquired Immunodeficiency Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Regions (2019-2024)
Table 18. Global Acquired Immunodeficiency Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Country (2019-2024)
Table 22. Americas Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 24. Americas Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 26. APAC Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Table 28. APAC Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 30. APAC Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 32. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Country (2019-2024)
Table 34. Europe Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 36. Europe Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Acquired Immunodeficiency Syndrome
Table 45. Key Market Challenges & Risks of Acquired Immunodeficiency Syndrome
Table 46. Key Industry Trends of Acquired Immunodeficiency Syndrome
Table 47. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Takeda Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 52. Takeda Acquired Immunodeficiency Syndrome Product Offered
Table 53. Takeda Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
Table 56. AstraZeneca Eli Lilly and Company Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 57. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Offered
Table 58. AstraZeneca Eli Lilly and Company Main Business
Table 59. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. AstraZeneca Eli Lilly and Company Latest Developments
Table 61. Merck KGaA Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 62. Merck KGaA Acquired Immunodeficiency Syndrome Product Offered
Table 63. Merck KGaA Main Business
Table 64. Merck KGaA Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Merck KGaA Latest Developments
Table 66. Sanofi Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 67. Sanofi Acquired Immunodeficiency Syndrome Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sanofi Latest Developments
Table 71. Pfizer Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 72. Pfizer Acquired Immunodeficiency Syndrome Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Amgen Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 77. Amgen Acquired Immunodeficiency Syndrome Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Latest Developments
Table 81. Biogen Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 82. Biogen Acquired Immunodeficiency Syndrome Product Offered
Table 83. Biogen Main Business
Table 84. Biogen Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Biogen Latest Developments
Table 86. Novartis Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 87. Novartis Acquired Immunodeficiency Syndrome Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Novartis Latest Developments
Table 91. Actelion Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 92. Actelion Acquired Immunodeficiency Syndrome Product Offered
Table 93. Actelion Main Business
Table 94. Actelion Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Actelion Latest Developments
Table 96. Daiichi Sankyo Company Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 97. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Offered
Table 98. Daiichi Sankyo Company Main Business
Table 99. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Daiichi Sankyo Company Latest Developments
Table 1. Acquired Immunodeficiency Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Major Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Acquired Immunodeficiency Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 7. Acquired Immunodeficiency Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 10. Global Acquired Immunodeficiency Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Player (2019-2024)
Table 12. Acquired Immunodeficiency Syndrome Key Players Head office and Products Offered
Table 13. Acquired Immunodeficiency Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Acquired Immunodeficiency Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Regions (2019-2024)
Table 18. Global Acquired Immunodeficiency Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Country (2019-2024)
Table 22. Americas Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 24. Americas Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 26. APAC Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Table 28. APAC Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 30. APAC Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 32. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Country (2019-2024)
Table 34. Europe Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 36. Europe Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Acquired Immunodeficiency Syndrome
Table 45. Key Market Challenges & Risks of Acquired Immunodeficiency Syndrome
Table 46. Key Industry Trends of Acquired Immunodeficiency Syndrome
Table 47. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Acquired Immunodeficiency Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Takeda Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 52. Takeda Acquired Immunodeficiency Syndrome Product Offered
Table 53. Takeda Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
Table 56. AstraZeneca Eli Lilly and Company Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 57. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Offered
Table 58. AstraZeneca Eli Lilly and Company Main Business
Table 59. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. AstraZeneca Eli Lilly and Company Latest Developments
Table 61. Merck KGaA Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 62. Merck KGaA Acquired Immunodeficiency Syndrome Product Offered
Table 63. Merck KGaA Main Business
Table 64. Merck KGaA Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Merck KGaA Latest Developments
Table 66. Sanofi Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 67. Sanofi Acquired Immunodeficiency Syndrome Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sanofi Latest Developments
Table 71. Pfizer Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 72. Pfizer Acquired Immunodeficiency Syndrome Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Amgen Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 77. Amgen Acquired Immunodeficiency Syndrome Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Latest Developments
Table 81. Biogen Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 82. Biogen Acquired Immunodeficiency Syndrome Product Offered
Table 83. Biogen Main Business
Table 84. Biogen Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Biogen Latest Developments
Table 86. Novartis Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 87. Novartis Acquired Immunodeficiency Syndrome Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Novartis Latest Developments
Table 91. Actelion Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 92. Actelion Acquired Immunodeficiency Syndrome Product Offered
Table 93. Actelion Main Business
Table 94. Actelion Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Actelion Latest Developments
Table 96. Daiichi Sankyo Company Details, Company Type, Acquired Immunodeficiency Syndrome Area Served and Its Competitors
Table 97. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Offered
Table 98. Daiichi Sankyo Company Main Business
Table 99. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Daiichi Sankyo Company Latest Developments
LIST OF FIGURES
Figure 1. Acquired Immunodeficiency Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Acquired Immunodeficiency Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Acquired Immunodeficiency Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Acquired Immunodeficiency Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type in 2023
Figure 10. Acquired Immunodeficiency Syndrome in Hospital Pharmacy
Figure 11. Global Acquired Immunodeficiency Syndrome Market: Hospital Pharmacy (2019-2024) & ($ Millions)
Figure 12. Acquired Immunodeficiency Syndrome in Retail Pharmacy
Figure 13. Global Acquired Immunodeficiency Syndrome Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 14. Acquired Immunodeficiency Syndrome in Others
Figure 15. Global Acquired Immunodeficiency Syndrome Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application in 2023
Figure 17. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Player in 2023
Figure 18. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. APAC Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Europe Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 23. Americas Acquired Immunodeficiency Syndrome Value Market Share by Country in 2023
Figure 24. United States Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Region in 2023
Figure 29. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Type in 2023
Figure 30. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Application in 2023
Figure 31. China Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Country in 2023
Figure 38. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Figure 39. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Figure 40. Germany Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. APAC Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. Europe Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. United States Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Canada Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. China Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Japan Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. Korea Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. India Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. Australia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. Germany Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. France Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. UK Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Italy Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Russia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. Spain Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. Israel Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 78. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Acquired Immunodeficiency Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Acquired Immunodeficiency Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Acquired Immunodeficiency Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Acquired Immunodeficiency Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Type in 2023
Figure 10. Acquired Immunodeficiency Syndrome in Hospital Pharmacy
Figure 11. Global Acquired Immunodeficiency Syndrome Market: Hospital Pharmacy (2019-2024) & ($ Millions)
Figure 12. Acquired Immunodeficiency Syndrome in Retail Pharmacy
Figure 13. Global Acquired Immunodeficiency Syndrome Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 14. Acquired Immunodeficiency Syndrome in Others
Figure 15. Global Acquired Immunodeficiency Syndrome Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Application in 2023
Figure 17. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Player in 2023
Figure 18. Global Acquired Immunodeficiency Syndrome Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. APAC Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Europe Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size 2019-2024 ($ Millions)
Figure 23. Americas Acquired Immunodeficiency Syndrome Value Market Share by Country in 2023
Figure 24. United States Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Region in 2023
Figure 29. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Type in 2023
Figure 30. APAC Acquired Immunodeficiency Syndrome Market Size Market Share by Application in 2023
Figure 31. China Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Country in 2023
Figure 38. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Figure 39. Europe Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Figure 40. Germany Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Acquired Immunodeficiency Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. APAC Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. Europe Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. United States Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Canada Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. China Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Japan Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. Korea Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. India Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. Australia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. Germany Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. France Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. UK Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Italy Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Russia Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. Spain Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. Israel Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Acquired Immunodeficiency Syndrome Market Size 2025-2030 ($ Millions)
Figure 78. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Acquired Immunodeficiency Syndrome Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Scalpel Blade Removers Market Growth 2024-2030
US$ 3,660.00
December 2024
93 pages
Global Antimicrobial Regenerative Wound Matrix Market Growth 2023-2029
US$ 3,660.00
March 2023
109 pages
Global 3D Printing for Surgical Procedures Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Cardiovascular Catheter Stabilization Market Growth 2023-2029
US$ 3,660.00
February 2023
111 pages
